Search Results

1 - 10 of 86 items :

  • "prostate cancer" x
  • Basic Medical Science x
Clear All
Mir-15A Reconstitution in Prostate Cancer Cell Line Suppresses Cancer Progression Through Down Regulation of MYB and Androgen Receptor Upregulation

, 2005 102(39), 13944-9. 4. Heinlein C. A. et C. Chang. Androgen receptor in prostate cancer. - Endocr. Rev., 25, 2004, N 2, 276-308. 5. Jun-jie YU and XIA Shu-jie. Novel role of microRNAs in prostate cancer. - Chin. Med. J., 126, 2013; N15, 2960-4. 6. Kalkbrenner F., S. Guehmann et K. Moelling. Transcriptional activation by human c-myb and v-myb genes. - Oncogene, 5, 1990, N 5, 657-661. 7. Lagos-Quintana M., R. Rauhut, A. Yalcin et al. Identification of tissue-specific MicroRNAs from mouse. - Curr. Biol

Open access
Polymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer

References Simard J, Dumont M, Labuda, Sinnett D, Meloche C, El-Alfy M, Berger L, Lees E, Labrie F, Tavtigian SV. Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer. 2003; 10(2): 225-259. Takaku H, Minagawa W, Takagi M, Nashimot M. The N-terminal half-domain of the long form of tRNase Z is required for the Rnase 65 activity. Nucleic Acids Res. 2004; 32(15): 4429-4438. Kover W, Guevara C, Chen, Y. Neuteboom S, Bookstein R, Tavtigian S

Open access
The Role of microRNA-15A in the Development of Prostate Cancer – Effects on Cell Proliferation and Pro-Inflammatory Signalling

REFERENCES 1. Siegel R. Cancer statistics, A cancer journal for Clinicians, 2013, 63 11-30. 2. Tam WBD. A novel gene activated by proviral insertions in avian leukosis virus – induced lymphomas is likely to function through its noncoding RNA. Moll Cell Biol, 1997, 17: 1490-502. 3. Kato T, Fujita Y, Nakane K et al. Ets1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-re-fractory pc3 prostate cancer cells by up-regulating mdr1 and mmp9 expression. Biochem Biphys Res Commun, 2012, 417:966-71. 4. Mitchell PS, Parkin RK

Open access
Proteomics in Diagnosis of Prostate Cancer/ Протеомика Во Дијагноза На Простатниот Карцином

References 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-2917. 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1): 5-29. 3. Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer. 2008; 8(4): 268-278. 4. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate

Open access
in PRILOZI
Cag Repeat Number in the Androgen Receptor Gene and Prostate Cancer

References Crawford ED. Epidemiology of prostate cancer. Urology. 2003; 62(6): 3-12. Gronberg H. Prostate cancer epidemiology. Lancet. 2003; 361(9360): 859-864. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin. 1997; 47(5): 273-287. Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer. 2011; doi: 10.1002/cncr.26392. [Epub

Open access
Shift Work and Cancer: State of Science and Practical Consequences

;158:35-46. Blettner M, Zeeb H, Auvinen A, Ballard TJ, Caldora M, Eliasch H, Gundestrup M, Haldorsen T, Hammar N, Hammer GP, Irvine D, Langner I, Paridou A, Pukkala E, Rafnsson V, Storm H, Tulinius H, Tveten U, Tzonou A. Mortality from cancer and other causes among male airline cockpit crew in Europe. Int J Cancer 2003:106:946-52. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, Miki T, Nakao M, Hayashi K, Suzuki K, Mori M, Washio M, Sakauchi F, Ito Y, Yoshimura T, Tamakosh A. Prospective cohort study of the risk of prostate cancer among rotating

Open access
Sodium-glucose cotransporters: new targets of cancer therapy?

50. Ghezzi C, Wright EM. Regulation of the human Na+- dependent glucose cotransporter hSGLT2. Am J Physiol-Cell Ph 2012;303:C348-54. doi: 10.1152/ajpcell.00115.2012 51. Siegel RL, Miller KD, Jemal A. Cancer Statistics. CA Cancer J Clin 2017;67:7-30. doi: 10.3322/caac.21387 52. Vaz CV, Marques R, Alves MG, Oliveira PF, Cavaco JE, Maia CJ, Socorro S. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. J Cancer Res Clin Oncol

Open access
The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

between the del5395 mutation and increased cancer risk, while the missense mutation I157T was found to play a role in cancer development. Presence of the del 5395 mutation is associated with an increased prostate cancer risk [ 3 ]. On the other hand, the CHEK2 mutations, including del5395, decrease the risk of lung and laryngeal cancers [ 7 ]. Most of the del5395 research is based on the Polish population. Thus, due to the lack of studies conducted in other Eastern European countries, we undertook to find out the following: 1) whether the del5395 is a founder

Open access
Epidemiological trends of hormone-related cancers in Slovenia

CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010;362:1192-202. doi: 10.1056/NEJMoa0908127 44. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Screening and prostate-cancer mortality in a

Open access
Prostate-Specific Antigen (PSA) in Serum in Relation to Blood Lead Concentration and Alcohol Consumption in Men

References Collins GN, Lee RJ, McKelvie GB, Rogers AC, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993;71:445-50. Hrvatski zavod za javno zdravstvo, Služba za epidemiologiju, Registar za rak. Incidencija raka u Hrvatskoj 2005 [Croatian Health Care Institute Cancer Registry. Cancer incidence in Croatia in 2005, in Croatian]. Bilten 2007;(30). Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin

Open access